The 20 Best Optic Glioma Doctors Near Me in District of Columbia, US

Roger Packer is a Pediatrics provider practicing medicine in Washington, Washington, D.c.. Dr. Packer is rated as a Distinguished provider by MediFind in the treatment of Optic Glioma. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Brain Tumor, Diffuse Midline Glioma H3 K27M-Mutant, Medulloblastoma, and Gliomatosis Cerebri.

Lynn Huang is a Neuroradiologist practicing medicine in Washington, Washington, D.c.. Dr. Huang is rated as an Advanced provider by MediFind in the treatment of Optic Glioma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Pleurisy, Pleural Effusion, Nasal Flaring, and Cerebral Arteriovenous Malformation.

Steven Stasheff is a Pediatric Neurologist practicing medicine in Washington, Washington, D.c.. He has been practicing medicine for over 34 years. Dr. Stasheff is rated as an Advanced provider by MediFind in the treatment of Optic Glioma. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Neurofibromatosis, Optic Glioma, Gomez Lopez Hernandez Syndrome, and Marcus Gunn Phenomenon. Dr. Stasheff is board certified in American Board Of Psychiatry And Neurology, 1999.

Lindsay Kilburn, MD, comes to Children's National Hospital from Texas Children’s Hospital in Houston, TX, where she was an assistant professor of pediatrics in the neuro-oncology and pharmacology programs. Dr. Kilburn graduated with a degree in Environmental Sciences from the University of Virginia. After graduating from Eastern Virginia Medical School, she completed her pediatric training at the Children’s Hospital of The King’s Daughters in Norfolk, VA, and her hematology/oncology fellowship at Texas Children’s Hospital/Baylor College of Medicine in Houston, TX. She also has received training in pharmacology from both Thomas Jefferson University in Philadelphia and the Baylor College of Medicine in Houston. Dr. Kilburn is an associate professor, pediatrics at George Washington University School of Medicine. Her research focuses on the development and evaluation of new therapeutic agents for children with pediatric brain tumors through clinical trials. She is committed to the improvement of palliative and supportive care. Dr. Kilburn grew up outside of Philadelphia and is married with young twins. Outside of work, she enjoys sailing, hiking, and traveling with her family. Dr. Kilburn is rated as an Advanced provider by MediFind in the treatment of Optic Glioma. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Diffuse Midline Glioma H3 K27M-Mutant, Brain Stem Cancer, Glioma, and Optic Glioma. Dr. Kilburn is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2009 and Pediatrics: American Board Of Pediatrics, 2004.

John Lichtenberger is a Radiologist practicing medicine in Washington, Washington, D.c.. Dr. Lichtenberger is rated as an Experienced provider by MediFind in the treatment of Optic Glioma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Pulmonary Vein Stenosis, Idiopathic Dilatation of the Pulmonary Artery, Emphysema, and Pleural Effusion.

Martin Kolsky is an Ophthalmologist practicing medicine in Washington, Washington, D.c.. Dr. Kolsky is rated as an Advanced provider by MediFind in the treatment of Optic Glioma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Optic Atrophy Type 1, Optic Nerve Atrophy, Glaucoma, and Optic Glioma.

"Eugene (Gene) Hwang, MD, is chief of the Division of Oncology at Children’s National Hospital in Washington, D.C. He is also part of the Children's National Hospital pediatric neuro-oncology team, focusing on treating children with brain tumors. Dr. Hwang has developed and led many novel early phase therapeutic clinical trials with a focus on immunotherapeutic trials, and he also leads trials focused on gene therapy and new, targeted agents. He is the site Principal Investigator of the Pediatric Brain Tumor Consortium, where he is the co-chair of the Immunotherapy Working Group. He serves on grant review committees and on the scientific advisory boards of several large foundations. For each patient, Dr. Hwang carefully considers the best possible options for treatment, trying new, cutting edge treatments coupled with the best available known therapies. Dr. Hwang is not only dedicated to finding a cure for cancer, but also to making the current treatments as safe as possible for children: ""We often focus on curing the children - that's the number one goal - but we also need to pay attention to the toxicity of these treatments, and what quality of life the children will have after treatment."" Dr. Hwang is involved in several international efforts to study how to best mitigate treatment side effects. In the meantime, Dr. Hwang makes sure he is doing everything he can to combat pain, dizziness, fatigue and other common side effects of cancer treatments by leveraging the multidisciplinary team approach of Children's National. He sees this as something the organization does exceptionally well, and thinks that having so many people focus on a single patient in a single visit is crucial to well-being during cancer treatment.". Dr. Hwang is rated as an Experienced provider by MediFind in the treatment of Optic Glioma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Pineocytoma, Glioma, Medulloblastoma, and Pineoblastoma. Dr. Hwang is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2009 and Pediatrics: American Board Of Pediatrics, 2005.

Brian R. Rood, MD, is the director of clinical neuro-oncology and the medical director of the Brain Tumor Institute at Children's National Hospital. Dr. Rood is also a principal investigator in the Center for Cancer and Immunology Research at Children's National Research Institute and a professor of pediatrics at the George Washington University School of Medicine and Health Sciences and adjunct professor at the Fralin Biomedical Research Institute at Virginia Tech. He received a Bachelor of Arts in English Literature from The Pennsylvania State University and completed medical school at Jefferson Medical College. He completed his pediatric residency training at the University of Vermont. Dr. Rood received his pediatric hematology/oncology training at Children's National. He joined the faculty of Children’s National in 2002 after completing a fellowship in pediatric hematology/oncology, as well as a research fellowship in the molecular biology of brain tumors, both at Children’s National and Children’s National Research Institute. Currently, Dr. Rood’s research focuses on the application of proteomics in cancer biology investigation, neoantigen identification and biomarker development. He has also been studying the contribution of germline microsatellite genotypes to pediatric brain tumor predisposition. He currently serves as the executive co-chair of the Children’s Brain Tumor Network, an international consortium of 28 institutions that maintains the world’s largest pediatric brain tumor tissue and data repository, which are freely provided to the research community to support the development of groundbreaking clinical trials through data-driven precision medicine. Dr. Rood has two children. His favorite pastimes include designing and building furniture, sailing, reading, and playing the mandolin. Dr. Rood is rated as an Experienced provider by MediFind in the treatment of Optic Glioma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Glioma, and Diffuse Midline Glioma H3 K27M-Mutant. Dr. Rood is board certified in Pediatric Hematology-Oncology: American Board Of Pediatrics, 2002 and Pediatrics: American Board Of Pediatrics, 1998.

Elizabeth Wells, MD, MHS, is the executive vice president, chief clinical officer and physician-in-chief. Dr. Wells has executive oversight for ensuring optimal delivery of clinical care while fostering an environment that supports research, education and operational excellence. In her previous role as senior vice president of the Neuroscience and Behavioral Medicine Center, she grew programmatic and research impact across multidisciplinary destination programs, quality and safety, and patient experience across the care continuum for brain injury and disorders, mental and behavioral health, and neurodevelopmental conditions. Dr. Wells previously held leadership roles in clinical research administration and served as president of the Children’s National Medical Staff from 2020 to 2021 and Credentials Committee chair from 2022 to 2023. Dr. Wells is a graduate of Harvard University and the George Washington University School of Medicine and Health Sciences. She holds a master’s degree in health science from the NIH/Duke Clinical Research Training Program. She completed pediatrics and neurology training at Children’s National and served as a pediatric neurologist within the Brain Tumor Institute and the Division of Neurology, rising to the rank of professor in Pediatrics, Neurology and Rehabilitation Medicine. Dr. Wells serves on the board for the Pediatric Specialists of Virginia, is past president of the Washington Clinico-Pathological Society and a graduate of Leadership Greater Washington's 2022 Signature class. In her new leadership role, Dr. Wells provides strategic, financial and administrative leadership across five centers of excellence, general pediatrics and multiple institutes, including about 3,000 employees, to advance high-quality outcomes and integrated services. Dr. Wells is rated as an Experienced provider by MediFind in the treatment of Optic Glioma. Her clinical expertise encompasses West Syndrome, Multisystem Inflammatory Syndrome in Children (MIS-C), Medulloblastoma, and Anti-NMDA Receptor Encephalitis. Dr. Wells is board certified in American Board Of Psychiatry And Neurology, 2011.